Efficacy and safety of long-acting injectable oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis

• Главные авторы: Giovanni Vita (Автор), Angelantonio Tavella (Автор), Giovanni Ostuzzi (Автор), Federico Tedeschi (Автор), Michele De Prisco (Автор), Rafael Segarra (Автор), Marco Solmi (Автор), Corrado Barbui (Автор), Christoph U. Correll (Автор)
• Формат: ‌
• Опубликовано: SAGE Publishing, 2024-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Long-acting injectable antipsychotics (LAIs) have advantages over oral antipsychotics (OAPs) in preventing relapse and hospitalization in chronically ill patients with schizophrenia-spectrum disorders (SSDs), but evidence in patients with first-episode/recent-onset, that is, early-phase-...